Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HEPARIN Cause Thrombophlebitis superficial? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Thrombophlebitis superficial have been filed in association with HEPARIN (Heparin Sodium). This represents 0.1% of all adverse event reports for HEPARIN.

15
Reports of Thrombophlebitis superficial with HEPARIN
0.1%
of all HEPARIN reports
3
Deaths
11
Hospitalizations

How Dangerous Is Thrombophlebitis superficial From HEPARIN?

Of the 15 reports, 3 (20.0%) resulted in death, 11 (73.3%) required hospitalization, and 6 (40.0%) were considered life-threatening.

Is Thrombophlebitis superficial Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HEPARIN. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does HEPARIN Cause?

Drug ineffective (2,294) Heparin-induced thrombocytopenia (2,057) Off label use (1,077) Thrombocytopenia (781) Haemorrhage (684) Pulmonary embolism (652) Drug hypersensitivity (629) Thrombosis (603) Foetal exposure during pregnancy (582) Anaemia (576)

What Other Drugs Cause Thrombophlebitis superficial?

DROSPIRENONE\ETHINYL ESTRADIOL (160) LENALIDOMIDE (121) ETHINYL ESTRADIOL\ETONOGESTREL (93) RIVAROXABAN (82) YAZ (78) YASMIN (65) TESTOSTERONE (62) HUMAN IMMUNOGLOBULIN G (43) ADALIMUMAB (40) CAPECITABINE (29)

Which HEPARIN Alternatives Have Lower Thrombophlebitis superficial Risk?

HEPARIN vs HEPARIN\SODIUM HEPARIN vs HEPATITIS B VIRUS VACCINE HEPARIN vs HERBALS HEPARIN vs HERBALS\MITRAGYNINE HEPARIN vs HERBALS\PAULLINIA CUPANA SEED

Related Pages

HEPARIN Full Profile All Thrombophlebitis superficial Reports All Drugs Causing Thrombophlebitis superficial HEPARIN Demographics